Celltrion Healthcare receives EU CHMP positive opinion for biosimilar adalimumab, CT-P17

INCHEON, South Korea–(BUSINESS WIRE)–Celltrion Healthcare today announced that the Committee for Medicinal Products for Human Use …

Read more